Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool
NCT ID: NCT05273021
Last Updated: 2024-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2021-07-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This will be investigated in 2 groups: patients without intellectual disabilities treated in Flexible Assertive Community Treatment (FACT) teams and patients with intellectual disabilities. For the later group, an adjusted version of the TAPS-tool will be developed.
For both groups the TAPS outcome will be compared to a golden standard.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Tobacco, Alcohol, Prescription Medication and Other Substances Tool
NCT02110693
Individualizing Incentives for Alcohol in the Severely Mentally Ill
NCT03481049
Contingency Management of Alcohol Abuse in the Severely Mentally ILL
NCT01567943
Evaluation of Web-Based Recovery Monitoring With Clinical Alerts
NCT01465555
Attentional Control Training for Treating Alcohol Use Disorder
NCT05102942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For people with intellectual disabilities (ID) who get an extensive assessment of substance use problems in their (standard) treatment, permission to participate on the TAPS (version for ID) was asked.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
participants with substance use problems
There are 2 subgroups:
* Participants without intellectual disabilities
* Participants with intellectual disabilities with and without severe mental illness
TAPS
all participants are investigated by the Dutch TAPS tool (Tobacco, Alcohol, Prescription medication and other Substances-tool). A screener and short assessment of possible substance use problems
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAPS
all participants are investigated by the Dutch TAPS tool (Tobacco, Alcohol, Prescription medication and other Substances-tool). A screener and short assessment of possible substance use problems
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ggz Oost Brabant
OTHER
Birgit Seelen-de Lang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birgit Seelen-de Lang
Psychologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GGZ Oost Brabant - FACT
Boekel, North Brabant, Netherlands
GGZ Oost Brabant - LVB-P
Boekel, North Brabant, Netherlands
Stichting ORO
Helmond, North Brabant, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form: ICF FACT
Document Type: Informed Consent Form: ICF LVB-P
Document Type: Informed Consent Form: ICF ORO
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECSW-2021-051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.